AIM
ONC

AIA Investment Management’s BeOne Medicines Ltd ONC Stock Holding History

AIA Investment Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$29K Hold
100
– – 0.01% 356
2020
Q2 		$19K Buy
+100
New +$16.3K ﹤0.01% 352

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

AIA Investment Management's ONC Position: Q3 2020 in Review

AIA Investment Management held its BeOne Medicines Ltd (ONC) position steady in Q3 2020 at 100 shares worth $29K. The position accounts for 0.01% of the portfolio, ranked #356.

AIA Investment Management first reported a position in ONC in Q2 2020 and has held it in 2 quarters since. 243 funds tracked by Wall St. Rank hold ONC as of Q3 2020.

  • AIA Investment Management held 100 shares of BeOne Medicines Ltd worth $29K as of Q3 2020.
  • AIA Investment Management left its BeOne Medicines Ltd share count unchanged in Q3 2020.
  • BeOne Medicines Ltd made up 0.01% of AIA Investment Management's portfolio in Q3 2020, its #356 holding.
  • AIA Investment Management first reported a position in BeOne Medicines Ltd in Q2 2020 and has held it in 2 quarters since.
  • 243 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2020.

Based on AIA Investment Management's 13F filing for Q3 2020, filed 16 Nov 2020.